Calendar Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 20:54:33 23/01/2026 GMT			5-day change	1st Jan Change
67.37 ^USD	-3.19%		+5.76%	+1.69%

01-22	B. Riley Raises Price Target on Arrowhead Pharmaceuticals to $101 From $61, Keeps Buy Rating	MT
01-13	Aligos Therapeutics, Inc. Appoints James Hassard as Executive Vice President and Chief Commercial Officer, Effective January 13, 2026	CI

Chart calendar Arrowhead Pharmaceuticals, Inc.

0ceac85d887601fe742d3f43d1.WTLrVuuW_WqQQblM4QBxKczKkg29POcNoFulEfFkgkU.MgGNYL3nxRP8DOA_lmMYToKopD36WbZ0-RzJVbUs4xUqSKIaoMSTOf553g~c682567b0c0bfc27cf5c0868657f713b

Upcoming events on Arrowhead Pharmaceuticals, Inc.

04/02/2026	Q1 2026 Earnings Release	Add to your calendar Google Apple ICS format
05/02/2026	Q1 2026 Earnings Call	Add to your calendar Google Apple ICS format
06/05/2026	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
05/08/2026	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
29/11/2026	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
09/02/2027	Q1 2027 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Arrowhead Pharmaceuticals, Inc.

12/01/2026	J.P. Morgan Healthcare Conference
06/01/2026	Investor Meeting - KOL
10/12/2025	CNS Delivery Summit
04/12/2025	Evercore Healthcare Conference
03/12/2025	World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease
03/12/2025	Piper Sandler Healthcare Conference
25/11/2025	Q4 2025 Earnings Call
25/11/2025	Q4 2025 Earnings Release
24/11/2025	TD Cowen Treatment Advancements in Obesity and Related Disorders Summit
19/11/2025	Jefferies Global Healthcare Conference
18/11/2025	REDEMPLO® (plozasiran) FDA Approval Call
10/11/2025	American Heart Association Meeting - Gerald Watts
09/11/2025	American Association for the Study of Liver Diseases Meeting - E SERUM MICRORNA SEQUENCING IDENTIFIE
09/11/2025	American Association for the Study of Liver Diseases Meeting - LIVER STIFFNESS RESPONSE AND HETEROGE
09/11/2025	American Association for the Study of Liver Diseases Meeting - ARTIFICIAL INTELLIGENCE-BASED QFIBROS
09/11/2025	American Association for the Study of Liver Diseases Meeting - FAZIRSIRAN IS EFFECTIVE IN EARLY AND
10/09/2025	RNA Leaders USA Congress
10/09/2025	Morgan Stanley Global Healthcare Conference
09/09/2025	H.C. Wainwright Global Investment Conference
04/09/2025	Cantor Global Healthcare Conference

Annual results

Fiscal Period	September	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	241 264 -8.67%	3,55 61,6 -94.24%	829 757 9.51%	399	291	495
EBITDA Million USD	Released Forecast Spread	-193 -159 -21.17%	-582 -536 -8.69%	122 126 -3.14%	-297	-534	-621
EBIT Million USD	Released Forecast Spread	-205 -162 -26.6%	-601 -557 -7.95%	98,3 73,1 34.59%	-418	-586	-484
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-206 -159 -29.54%	-612 -552 -10.94%	51,5 4,70 996.14%	-474	-613	-435
Net income Million USD	Released Forecast Spread	-205 -151 -36.13%	-599 -535 -11.97%	-1,63 1,67 -197.46%	-458	-572	-434
EPS USD	Released Forecast Spread	-1,92 -1,51 -26.73%	-5,00 -4,52 -10.67%	-0,01 -0,01 -33.33%	-3,39	-4,03	-2,97
Announcement Date		29/11/23	26/11/24	25/11/25	-

Quarterly results

Fiscal Period	September	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million USD	Released Forecast Spread	0,00 56,8 -	0,00 37,1 -	0,00 58,9 -	2,50 19,1 -86.88%	543 116 366.77%	27,8 29,0 -4.28%	256 157 63.04%	231	62,0	44,9	49,1	56,4	39,7	42,3	157
EBITDA Million USD	Released Forecast Spread	-122 -86,9 -39.99%	-171 -0,80 -21319.88%	-157 -134 -17.65%			-159 -90,0 -77.04%	50,5 32,0 57.88%	223	-139	-183	-198
EBIT Million USD	Released Forecast Spread	-126 -42,3 -198.14%	-176 -76,2 -131.05%	-162 -121 -34.53%	-161 -148 -8.76%	381 -50,2 859.27%	-166 -136 -21.62%	44,1 -25,3 274.12%	2,63	-148	-176	-174	-166	-168	-164	-167
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-127 -38,4 -230.34%	-174 -80,1 -117.22%	-173 -102 -69.53%	-175 -145 -20.88%	370 16,5 2137.84%	-179 -135 -33.1%	36,1 -41,9 186.23%	-34,0	-154	-180	-176	-176	-180	-178	-182
Net income Million USD	Released Forecast Spread	-125 -15,6 -705.53%	-171 -72,0 -137.12%	-171 -97,0 -75.83%	-173 -139 -24.41%	370 -12,5 3072.48%	-175 -137 -28.17%	-23,8 -41,4 42.66%	-27,6	-153	-175	-171	-176	-181	-179	-184
EPS USD	Released Forecast Spread	-1,02 -0,22 -369.12%	-1,38 -0,57 -140.61%	-1,37 -0,87 -57.26%	-1,39 -0,38 -264.59%	2,75 0,01 34189.28%	-1,26 -0,99 -27.39%	-0,18 -0,30 39.08%	-0,15	-1,14	-1,28	-1,25	-1,12	-1,26	-1,27	-0,66
Announcement Date		09/05/24	08/08/24	26/11/24	10/02/25	12/05/25	07/08/25	25/11/25	-	-	-	-	-	-	-	-

Upcoming sector events for Arrowhead Pharmaceuticals, Inc.

25/01/2026	SAMSUNG EPIS HOLDINGS CO., LTD.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
04/02/2026	ARROWHEAD PHARMACEUTICALS, INC.	Q1 2026 Earnings Release	Add to your calendar Google Apple ICS format
04/02/2026	ANAVEX LIFE SCIENCES CORP.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
05/02/2026	GENMAB A/S	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
09/02/2026	EXELIXIS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
10/02/2026	VIKING THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
10/02/2026	REZOLUTE, INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
11/02/2026	BIOCON LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
11/02/2026	AGIOS PHARMACEUTICALS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
11/02/2026	PROTHENA CORPORATION PLC	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

More events

Past sector events for Arrowhead Pharmaceuticals, Inc.

09/01/2026	LUMOSA THERAPEUTICS CO., LTD.	December 2025 Sales and Revenue Release
07/01/2026	TAIMED BIOLOGICS INC.	December 2025 Sales and Revenue Release
05/01/2026	PHARMAESSENTIA CORPORATION	December 2025 Sales and Revenue Release
22/12/2025	ENGENE HOLDINGS INC.	Q4 2025 Earnings Release
14/12/2025	SANBIO COMPANY LIMITED	Q3 2025 Earnings Release
08/12/2025	LUMOSA THERAPEUTICS CO., LTD.	November 2025 Sales and Revenue Release
05/12/2025	PHARMAESSENTIA CORPORATION	November 2025 Sales and Revenue Release
05/12/2025	TAIMED BIOLOGICS INC.	November 2025 Sales and Revenue Release
04/12/2025	MAPLIGHT THERAPEUTICS, INC.	Q3 2025 Earnings Release
03/12/2025	KALVISTA PHARMACEUTICALS, INC.	Q2 2026 Earnings Release (Projected)